3-(2-Ethyl-1H-imidazol-5-yl)propanoic acid | 1198843-42-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-(2-Ethyl-1H-imidazol-5-yl)propanoic acid
• 英文别名: 2-Ethyl-1H-imidazole-5-propanoic acid
• CAS: 1198843-42-3
• 化学式: C₈H₁₂N₂O₂
• 分子量: 168.195
• InChiKey: FWXXFVVABHHEEX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  66
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Piperidine derivative and use thereof
  申请人：Ikeura Yoshinori

  公开号：US20060142337A1

  公开（公告）日：2006-06-29

  The present invention provides a compound represented by the formula: wherein Ar is an aryl group optionally having substituents, R is a C 1-6 alkyl group, R 1 is a hydrogen atom, a hydrocarbon group optionally having substituents, an acyl group or a heterocyclic group optionally having substituents, X is an oxygen atom or an imino group optionally having substituents, ring A is a piperidine ring optionally further having substituents, and ring B is a benzene ring having substituents, or a salt thereof, and an agent for the prophylaxis or treatment of lower urinary tract abnormality and the like, which contains the compound.

  本发明提供了一种由以下公式表示的化合物： 其中Ar是一个芳基基团，可选地具有取代基，R是一个C1-6烷基基团，R1是一个氢原子，一个可选地具有取代基的烃基团，酰基团或杂环基团，X是一个氧原子或一个可选地具有取代基的亚胺基团，环A是一个哌啶环，可选地进一步具有取代基，环B是一个苯环，具有取代基，或其盐，以及含有该化合物的预防或治疗下尿道异常等的药剂。
• PIPERIDINE DERIVATIVES AND USE THEREOF
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1790636A1

  公开（公告）日：2007-05-30

  The present invention provides a compound represented by the formula: wherein Ar is an aryl group optionally having substituents, R is a C1-6 alkyl group, R1 is a hydrogen atom, a hydrocarbon group optionally having substituents, an acyl group or a heterocyclic group optionally having substituents, X is an oxygen atom or an imino group optionally having substituents, ring A is a piperidine ring optionally further having substituents, and ring B is a benzene ring having substituents, or a salt thereof, and an agent for the prophylaxis or treatment of lower urinary tract abnormality and the like, which contains the compound.

  本发明提供了一种由式表示的化合物： 其中 Ar 是任选具有取代基的芳基，R 是 C1-6 烷基，R1 是氢原子、任选具有取代基的烃基、酰基或任选具有取代基的杂环基，X 是氧原子或任选具有取代基的亚氨基，环 A 是任选进一步具有取代基的哌啶环，环 B 是具有取代基的苯环，或其盐，以及含有该化合物的预防或治疗下尿路异常等疾病的制剂。
• UROCANIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES
  申请人：Kammeijer Arthur

  公开号：US20100197752A1

  公开（公告）日：2010-08-05

  The invention relates to derivatives of urocanic acid that have improved efficacy and/or tissue penetration properties. The invention further provides use of these derivatives in a medicament for modulating an immune-related disease in an individual. Imidazole derivative, or a salt thereof, selected from O I1 W—C—R1 H— (formula 1); o I1 W—C—R1 and HN N r<1 NH (formula 2); O O Ov ̂ W—C—R1 and HN N (formula 3);